AzTrials
AzTrials

Club FootNCT04897100

Outcome After Needle vs Blade Achilles Tenotomy in Clubfoot

A study testing Achilles tendon tenotomy in people with Club Foot and Achilles Tendon Surgery, run by Indus Hospital and Health Network at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Achilles tendon tenotomy is an integral part of the Ponseti method, aimed at correcting residual equinus after correction of the adductus deformity. Tenotomy rates ranging from 63-95% after full cycle of castings have been reported in literature. Read more about this study

Who is it for?
Ages Up to 36 months
Conditions the study is for
Club Foot, Achilles Tendon Surgery
What is being tested?
Achilles tendon tenotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
244 participants
Where
1 sitePakistan
Study dates
27 Mar 2020to 16 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 36 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Idiopathic clubfoot.
  • Age less than or equal to 36 months at the time of tenotomy.
  • Enrolled at the Pehla Qadam clinic at The Indus Hospital in Karachi.
  • Fully corrected Adductus deformity with residual equinus after a full casting cycle.
  • Completing routine follow up for 3 months post tenotomy.

Who cannot join

  • Refusal of parents to enroll child into this study.
  • Syndromic clubfoot.
  • Previous treatment for clubfoot (surgical or non-surgical) received.
  • Underlying medical conditions unrelated to clubfoot that may serve as a contra-indication, this decision will be left on the discretion of the treating orthopedic surgeon

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Indus Hospital

    Karachi, Sindh

Other trials in Pakistan

About this study

Official title: Outcome and Complications After Percutaneous Needle Versus Blade Achilles Tenotomy in Clubfoot Treated With the Ponseti Method

Achilles tendon tenotomy is an integral part of the Ponseti method, aimed at correcting residual equinus after correction of the adductus deformity. Tenotomy rates ranging from 63-95% after full cycle of castings have been reported in literature. Percutaneous tenotomy is the gold standard, which can usually be performed in an out-patient setting under local anesthesia using a scalpel blade. A complication rate of 2% (mainly neurovascular injury)has been reported in literature, with accidental sectioning of the peroneal artery being the most common. Development of a pseudo-aneurysm after accidental sectioning of the peroneal artery has been reported in a case report; this delayed further clubfoot treatment.

Percutaneous needle tenotomy has been described by some authors as an alternative technique with very favorable results in a population before walking age. This technique use a large-gauge (16-19 G) needle to percutaneously cut the Achilles tendon. Although bleeding has been reported following this technique with similar rates as for the percutaneous blade technique, no major complications have been reported as yet using the needle technique.

We would like to compare the clinical outcomes and complication rates of both techniques, supporting our hypothesis that both techniques are equally safe and have the same success rate.

Being tested
Achilles tendon tenotomy
Medical subject headings
Clubfoot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Achilles tendon tenotomyProcedure or surgery

    Achilles tendon tenotomy during Ponseti treatment for clubfoot

Study groups in NCT04897100
Study groupRoleWhat they receive
Needle tenotomyExperimentalPatient will receive an Achilles tendon tenotomy using a 22G needle when randomized into the needle group. Follow-up to measure dorsiflexion and register complications will be assured at 3 weeks and 3 months.
Receives: Procedure: Achilles tendon tenotomy
Blade tenotomyActive comparatorPatient will receive an Achilles tendon tenotomy using a 11 blade when randomized into the needle group. Follow-up to measure dorsiflexion and register complications will be assured at 3 weeks and 3 months.
Receives: Procedure: Achilles tendon tenotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dorsiflexion

    Ankle dorsiflexion measured in degrees

    Measured: 3 months

Secondary outcomes (1)
  1. Complications

    Post-op complications due to tenotomy

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2021
  2. Study start27 Mar 2020
  3. Primary completion2 Sep 2023
  4. Study completion16 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
244 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04897100
Sponsor's protocol ID
IRD_IRB_2020_03_011
Status last verified
Mar 2024
First submitted
18 May 2021
Last updated
12 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The participant data will be made available in an anonymous manner as a supplement to the final publication

Publications

  • Pigeolet M, Ghufran Syed J, Ahmed S, Chinoy MA, Khan MA. A single-center, single-blinded, randomized, parallel-group, non-inferiority trial to compare the efficacy of a 22-gauge needle versus a 15 blade to perform an Achilles tendon tenotomy in 244 clubfeet-study protocol. Trials. 2023 Oct 31;24(1):701. doi: 10.1186/s13063-023-07728-9.

    PubMed 37907927

Questions about this trial

What is this clinical trial studying?

A study testing Achilles tendon tenotomy in people with Club Foot and Achilles Tendon Surgery, run by Indus Hospital and Health Network at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dorsiflexion (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04897100, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in